-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
AbbVie Inc. annual Current Federal Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- AbbVie Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $3.27 B, a 23.6% increase from 2022.
- AbbVie Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $2.65 B, a 33.2% increase from 2021.
- AbbVie Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $1.99 B, a 119% increase from 2020.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)